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Introduction
Strychnine is a bitter, white, powder alkaloid derived from
the seeds of the tree Strychnos nux-vomica. It has had an
interesting past, initially having been introduced in the 16th
century as a rodenticide, and until recently it was used as a
respiratory, circulatory and digestive stimulant [1]. It is no
longer used in any pharmaceutical products, but is still
used as a rodenticide. Strychnine is also found as an adul-
terant in street drugs such as amphetamines, heroin and
cocaine [2,3].
Strychnine poisoning is uncommon, and in most severe
cases, the patient dies before reaching hospital [4]. The man-
agement of strychnine poisoning is well documented, but
there is less information available about the elimination kinet-
ics of strychnine. We report the toxicokinetics of strychnine in
a patient who survived a deliberate strychnine ingestion.
Case report
A 42-year-old man with no significant past medical history pre-
sented approximately 1 hour after ingestion of a bottle of wine
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together with some “white powder” from his garden shed (this
was later confirmed to be strychnine). He was able to walk in
to the Emergency Department, but he was agitated and ataxic,
in keeping with his ethanol intake. Within a few minutes of his
arrival, his condition rapidly deteriorated and he developed a
marked tremor and muscular spasms and shortly after this had
a respiratory and secondary cardiac arrest. At this stage he
was intubated and ventilated, and cardiac output returned
after 5 minutes. He was transferred to the intensive care unit
(ICU) and the National Poisons Information Service (London)
was contacted for further advice on management.
He continued to have marked muscle spasms and so was
paralysed with 0.1 mg/kg pancuronium given intravenously.
He was given 50 g activated charcoal via a nasogastric tube.
Postarrest, his blood pressure was 85/40 mmHg, heart rate
96 beats/min and temperature 38.2°C. Arterial blood gases
showed a severe metabolic acidosis (pH 6.51, PaO2 9.5 kPa,
PaCO2 2.6 kPa, HCO3 3.7 mmol/l, base excess [BE] –18)
and he was given 3 mmol/kg 8.4% sodium bicarbonate; his
metabolic acidosis improved over the next 8 hours (pH 7.26,
PaCO2 5.35 kPa, PaO2 13.4 kPa, HCO3 18 mmol/l, BE –9).
He remained hypotensive despite fluid resuscitation and over
the first 24 hours he required norepinephrine to maintain his
blood pressure (maximum dose 900 µg/h). His temperature
rose to 39.9°C on day 2 but settled after simple cooling mea-
sures and rehydration. His creatinine kinase peaked at
8218 IU/l, (although there was no evidence of myoglobinuria)
and his creatinine peaked at 194 µmol/l on day 2.
He was extubated on day 3, initially with some persisting
twitching and muscular spasms, requiring boluses of midazo-
lam and diazepam and an alfentanil infusion for analgesia. By
day 5 he was asymptomatic and his renal function had
returned to normal. He was discharged from hospital on
day 10 after psychiatric assessment.
Results
Eight serum samples were obtained over the first 5 days and
subsequently analysed on a Hewlett–Packard 6890 gas
chromatograph (Stockport, Cheshire, UK) equipped with a
nitrogen phosphorous detector for strychnine concentrations.
A Restex RTX 1 column was used with an isothermal oven
temperature of 270°C. The injector and detector tempera-
tures were set at 250°C and 300°C, respectively. The strych-
nine concentrations are shown in Fig. 1; the patient’s initial
concentration at 1.5 hours after ingestion was 4.73 mg/l,
falling to 0.38 mg/l and to 0 at 74 hours and 100 hours
postingestion, respectively. The data conformed to a monoex-
ponential elimination curve and the calculated elimination
half-life was 12 hours.
Discussion
Strychnine poisoning is an uncommon but potentially fatal
poisoning and most patients die before reaching hospital. In
the case presented here, the patient presented early after
ingestion. He was initially asymptomatic but rapidly devel-
oped severe muscle spasms leading to respiratory arrest.
With meticulous supportive care in the ICU he made a com-
plete recovery.
The mechanism of action causing strychnine toxicity is well
understood. This poison is a competitive antagonist of the
inhibitory neurotransmitter glycine at receptors in the spinal
cord, brain stem and higher centres [5]. It results in increased
neuronal activity and excitability, leading to increased muscu-
lar activity. The classical features of strychnine poisoning
occur from 15 to 30 minutes after ingestion and include
heightened awareness, muscular spasms and twitches and
hypersensitivity to stimuli. In large ingestions, these can
progress to painful generalised convulsions, during and after
which the patient retains consciousness. The cause of death
is usually respiratory arrest secondary to respiratory muscle
spasms [6], although prolonged muscular spasm can lead to
hyperthermia, rhabdomyolysis and associated renal failure
due to myoglobinuria [7,8]. Severe metabolic acidosis can
occur due to increased lactate levels following repeated mus-
cular activity, although the lactate is rapidly removed once the
muscular spasms have been controlled [7].
Prompt recognition of poisoning and initiation of treatment
are required to prevent deterioration and death. Control of
convulsions and muscular spasms requires either high doses
of benzodiazepines, such as 1 mg/kg diazepam [9,10], or, in
resistant cases, paralysis with neuromuscular blockers such
as pancuronium [11]. In addition, meticulous supportive care
is required, and careful monitoring and observation for com-
plications such as acute renal failure.
Clinical effects of strychnine ingestion have been seen at
doses as small as 2 mg in a child and 20 mg in an adult
[12,13]. Survival after ingestion of large amounts has been
reported: 480 mg (24 mg/kg) in a child and 3750 mg in an
adult [14,15]. Death from strychnine ingestion has been
reported in adults after doses as low as 5 to 10 mg [16]. Since
Figure 1
Serum strychnine concentrations in a patient with severe strychnine
poisoning.
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severe, life-threatening features have been reported after the
ingestion of small amounts and patients can deteriorate rapidly,
strychnine ingestion should be regarded as potentially fatal and
the patient should be admitted to an ICU for close observation
and appropriate treatment. In this case, as with many other
reported cases, both the concentration of strychnine in the
preparation ingested and the amount taken were unknown.
The serum strychnine concentration of 4.73 mg/l at 1.5 hours
postingestion is the highest reported concentration that a
patient has survived. In previous reports, concentrations of
2.1 mg/l at 3 hours [17] and 3.8 mg/l at 0.5 hours [8] caused
death. The potential fatal serum concentration of strychnine is
not known and clinical features rather than the serum concen-
tration should guide management. At a postmortem, less than
4 hours after an intentional ingestion of strychnine, a serum
concentration of just 0.33 mg/l was found [4]. A postmortem
study showed that a strychnine concentration of 3.32 mg/l in
the blood of the inferior vena cava was associated with con-
centrations of 11.4 mg/l, 2.42 mg/kg, 2.32 mg/kg and
98.6 mg/kg in bile, brain, skeletal muscle and liver, respec-
tively [18]. Of the 50 reported cases of strychnine poisoning
in the past 36 years, only two nonfatal cases have included
data on serum strychnine concentrations [19,20]. Both of
these patients had much lower concentrations (1.6 mg/l at
4 hours after ingestion and 2.17 mg/l at 6 hours after inges-
tion, respectively) than that found in our patient.
The elimination and metabolism of strychnine are poorly
understood. Strychnine is rapidly absorbed from the gastro-
intestinal tract, with symptoms occurring within 10 to
20 minutes of ingestion [6,21]. It is also absorbed through
other mucous membranes, as in poisonings when strychnine
has been mistaken for cocaine [3]. Strychnine has been
shown in animal studies to be metabolised in the liver by
cytochrome P-450 microsomal enzymes [22], but 1–30% is
excreted unchanged in the urine [17,23]. The proportion of
strychnine excreted unchanged appears to be smaller when
larger amounts are ingested [21,24].
In our patient, elimination of strychnine obeyed first-order
kinetics with a half-life of 12 hours. Only three other papers
have reported on the elimination kinetics of strychnine, and
these provide conflicting views of its toxicokinetics. Edmunds
and colleagues were the first authors to describe the elimina-
tion of strychnine and theirs is the only other report on the
kinetics of strychnine in a patient who survived [19]. They
reported a 42-year-old man who ingested an unknown quan-
tity of strychnine and developed severe muscle cramps and
convulsions and had a respiratory arrest 35 minutes after
ingestion. In that case, the elimination of strychnine obeyed
first-order kinetics with a half-life of 10 hours, based on 19
blood samples collected over a 53-hour period, the first of
which was taken at 4 hours after ingestion. Palatnick et al.
also reported first-order kinetics with a half-life of 16 hours,
based on 18 serum concentrations over a 51-hour period in a
34-year-old man after ingestion of 125 ml of a 2% strychnine
solution [17]. Heiser et al. reported zero-order kinetics in a
fatal case in a 51-year-old man who presented after ingesting
4.8 g of strychnine [8]. His serum concentrations were mea-
sured in only five samples, ranging from 3.5 mg/l at 0.5 hours
after ingestion to <0.1 mg/l at 43 hours after ingestion.
The differences in the kinetics of strychnine found in our
patient from the kinetics in the above three cases almost cer-
tainly reflect the influence of clinical parameters such as dif-
ferent periods of hypotension, metabolic acidosis and renal
impairment, all of which would influence hepatic metabolism
and renal elimination of strychnine. However, the calculated
half-life of 12 hours in our patient is comparable to the half-
lives previously reported (10 hours and 16 hours), suggesting
that the true elimination half-life of strychnine lies between 10
and 16 hours.
Conclusion
We describe a case of severe strychnine poisoning with a
favourable outcome in which the strychnine half-life was
12 hours. The patient presented early, his symptoms were
recognised and meticulous supportive care was instituted
without delay. All of these factors were probably important in
preventing what would otherwise have been a fatal ingestion
of strychnine.
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